Xinmin Zhou Selected Research

histone DNA binding protein-1

1/2017

MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinmin Zhou Research Topics

Disease

12	Neoplasms (Cancer) 02/2021 - 12/2007
7	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 03/2013
7	Fibrosis (Cirrhosis) 05/2021 - 10/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018 - 12/2007
6	Lung Neoplasms (Lung Cancer) 11/2017 - 12/2007
4	Aortic Dissection 04/2020 - 10/2011
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 12/2010
4	Cardiomyopathies (Cardiomyopathy) 08/2017 - 04/2015
3	Hypothermia 01/2022 - 05/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2012
3	Liver Diseases (Liver Disease) 01/2020 - 12/2013
3	Liver Failure 01/2019 - 01/2017
3	Myocardial Infarction 06/2014 - 01/2007
2	Hematoma 02/2020 - 05/2016
2	Thrombosis (Thrombus) 01/2019 - 07/2012
2	Pulmonary Embolism 04/2018 - 02/2018
2	Embolism (Embolus) 04/2018 - 02/2018
2	Glycogen Storage Disease Type IIb 01/2018 - 08/2017
2	Carcinogenesis 11/2017 - 01/2014
2	Stomach Neoplasms (Stomach Cancer) 09/2017 - 09/2007
2	Cholestasis 08/2017 - 10/2013
2	Esophageal Squamous Cell Carcinoma 06/2017 - 12/2007
2	Inflammation (Inflammations) 01/2017 - 05/2013
2	Heart Failure 01/2016 - 08/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 05/2013
2	Reperfusion Injury 01/2015 - 01/2010
2	Skin Neoplasms (Skin Cancer) 01/2014 - 09/2013
1	Neurilemmoma (Schwannoma) 07/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Hypesthesia (Numbness) 01/2022
1	Acute-On-Chronic Liver Failure 01/2022
1	Nausea 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Vertigo (Positional Vertigo) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Paresthesia (Dysesthesia) 01/2022
1	Thromboembolism 01/2022
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 11/2021
1	Wounds and Injuries (Trauma) 06/2021
1	Thoracic Aortic Aneurysm 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Leukopenia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Hypertensive Intracranial Hemorrhage 02/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Disease Progression 01/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2017 - 01/2011
4	Pharmaceutical PreparationsIBA 02/2021 - 12/2007
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 05/2021 - 06/2013
3	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2014 - 12/2010
3	Phosphotransferases (Kinase)IBA 01/2014 - 12/2007
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2011 - 12/2007
2	AnticoagulantsIBA 01/2022 - 03/2013
2	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2013
2	Therapeutic UsesIBA 01/2020 - 02/2018
2	NucleosidesIBA 01/2020 - 03/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2009
2	EnzymesIBA 01/2018 - 11/2008
2	Messenger RNA (mRNA)IBA 11/2017 - 12/2007
2	BilirubinIBA 08/2017 - 03/2013
2	Cisplatin (Platino)FDA LinkGeneric 06/2017 - 08/2016
2	LipidsIBA 01/2017 - 03/2013
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2012
2	Angiotensin-Converting Enzyme 2IBA 06/2014 - 10/2013
2	chrysinIBA 01/2014 - 09/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 05/2013
2	Tyrosine (L-Tyrosine)FDA Link 01/2011 - 12/2007
1	Immunoglobulin M (IgM)IBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	Methadone (Dolophine)FDA LinkGeneric 01/2022
1	EsketamineIBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 05/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2021
1	C-Reactive ProteinIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 01/2021
1	apatinibIBA 01/2021
1	camrelizumabIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	NucleotidesIBA 01/2020
1	Forkhead Box Protein M1IBA 01/2020

Therapy/Procedure

12	Therapeutics 11/2021 - 01/2007
6	Transplantation 01/2019 - 01/2007
4	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022 - 01/2010
3	Stents 01/2019 - 03/2012
2	Operative Surgical Procedures 01/2022 - 04/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2021 - 06/2014
2	Vertebroplasty 04/2018 - 02/2018
1	Particle Accelerators 07/2022
1	Plasma Exchange 01/2022
1	Immunotherapy 01/2021
1	Deep Hypothermia Induced Circulatory Arrest 04/2020
1	Length of Stay 02/2020
1	Craniotomy 02/2020